Testimony, Briefings, Statements, & Reports
NRC Comments on Compounding Pharmacies: Loopholes that Kill
We call on Congress to work in a bipartisan manner to pass legislation necessary to protect our families from these predictable, preventable tragedies. Read More
Statement of NRC Senior Fellow Sonia Nagda, MD, MPH at the Pediatrics FDA Advisory Committee Meeting on Beyaz and Similar Oral Contraceptives, September 11, 2012
Sonia Nagda, a Senior Fellow at NRC, testifies at a Pediatrics FDA Advisory Committee meeting on the use of drospirenone-containing oral contraceptive, Beyaz, in pediatric populations. Read More
Statement of Dr. Diana Zuckerman, President, National Research Center for Women & Families: Supreme Court Ruling on the Affordable Care Act
Today’s Supreme Court ruling was a gift to millions of Americans who need and deserve essential health benefits but couldn’t afford it until now. Read More
Testimony of Dr. Diana Zuckerman, President at the FDA Advisory Committee Hearing on Metal-on-Metal Hip Implants
Metal-on-metal hip implants were approved by the FDA without requiring clinical studies before approval or following patients after their surgery for potential side effects. Now, 500,000 patients have metal-on-metal implants that have been widely reported to wear down and create metal debris inside patients’ bodies. Dr. Zuckerman testifies to the FDA about the lack of long-term clinical trials at their Advisory Committee hearing. Read More
NRC Comments to the CDC on Hepatitis C Virus Screening
NRC supports CDC’s expansion of guidelines for Hepatitis C screening for baby boomer adults. Read More
Statement of NRC Senior Fellow Sonia Nagda, MD, MPH at the FDA Advisory Committee Meeting on Atrial Septal Defect Occluders, May 24, 2012
Sonia Nagda, a Senior Fellow at NRC, testifies at an FDA advisory committee meeting on the post-market studies of atrial septal defect occluders. Read More
Statement of NRC Senior Fellow Sonia Nagda, MD, MPH, at the FDA Advisory Committee Meeting on Lorcaserin, May 10, 2012
Sonia Nagda, a Senior Fellow at NRC, testifies at an FDA advisory committee meeting on the weight loss drug Lorcaserin. Read More
What is missing from the debate over the Affordable Care Act? What’s in it for you.
The fate of the Affordable Care Act is now in the Supreme Court’s hands. Much of the debate has been political instead of focusing on how the law represents much-needed reform for the health care of all Americans. Read More
Statement of Paul Brown, In Support of the Ensuring Safe Medical Devices for Patients Act
Paul Brown, NRC’s Government Relations Manager released a statement supporting Senator Merkley’s bill, “Ensuring Safe Medical Devices for Patient Act” that requires the Food and Drug Administration (FDA) to establish a Unique Device Identifier (UDI) rule by the end of year and add medical devices to the Sentinel system. Read More
Statement of Brandel France de Bravo, MPH and Diana Zuckerman, PhD on Classification for Cranial Electrotherapy Stimulators
This testimony supported the FDA’s position that the available scientific evidence does not support reclassifying Cranial Electrotherapy Stimulators to a medical device category with lower risk. Read More